These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 16481077

  • 1. Experiments on a sub-unit vaccine encapsulated in microparticles and its efficacy against Brucella melitensis in mice.
    Estevan M, Gamazo C, Grilló MJ, Del Barrio GG, Blasco JM, Irache JM.
    Vaccine; 2006 May 08; 24(19):4179-87. PubMed ID: 16481077
    [Abstract] [Full Text] [Related]

  • 2. Brucella outer membrane complex-loaded microparticles as a vaccine against Brucella ovis in rams.
    Muñoz PM, Estevan M, Marín CM, Jesús De Miguel M, Jesús Grilló M, Barberán M, Irache JM, Blasco JM, Gamazo C.
    Vaccine; 2006 Mar 10; 24(11):1897-905. PubMed ID: 16337315
    [Abstract] [Full Text] [Related]

  • 3. Development and evaluation as vaccines in mice of Brucella melitensis Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis.
    Cloeckaert A, Jacques I, Grilló MJ, Marín CM, Grayon M, Blasco JM, Verger JM.
    Vaccine; 2004 Jul 29; 22(21-22):2827-35. PubMed ID: 15246618
    [Abstract] [Full Text] [Related]

  • 4. Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4.
    Winter AJ, Schurig GG, Boyle SM, Sriranganathan N, Bevins JS, Enright FM, Elzer PH, Kopec JD.
    Am J Vet Res; 1996 May 29; 57(5):677-83. PubMed ID: 8723881
    [Abstract] [Full Text] [Related]

  • 5. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
    Vemulapalli R, Contreras A, Sanakkayala N, Sriranganathan N, Boyle SM, Schurig GG.
    Vet Microbiol; 2004 Sep 08; 102(3-4):237-45. PubMed ID: 15327798
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of particulate acellular vaccines against Brucella ovis infection in rams.
    Da Costa Martins R, Irache JM, Blasco JM, Muñoz MP, Marín CM, Jesús Grilló M, Jesús De Miguel M, Barberán M, Gamazo C.
    Vaccine; 2010 Apr 09; 28(17):3038-46. PubMed ID: 19887131
    [Abstract] [Full Text] [Related]

  • 7. Influence of the co-encapsulation of different excipients on the properties of polyester microparticle-based vaccine against brucellosis.
    Murillo M, Irache JM, Estevan M, Goñi MM, Blasco JM, Gamazo C.
    Int J Pharm; 2004 Mar 01; 271(1-2):125-35. PubMed ID: 15129979
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Phenol-insoluble vaccine against human brucellosis: evaluation of the immunogenic power in guinea pigs].
    Bolpe J, de Lapenta DF, García-Carrillo C.
    Rev Inst Med Trop Sao Paulo; 1991 Mar 01; 33(1):23-7. PubMed ID: 1843392
    [Abstract] [Full Text] [Related]

  • 10. A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination.
    Cassataro J, Pasquevich KA, Estein SM, Laplagne DA, Velikovsky CA, de la Barrera S, Bowden R, Fossati CA, Giambartolomei GH, Goldbaum FA.
    Vaccine; 2007 May 30; 25(22):4437-46. PubMed ID: 17442465
    [Abstract] [Full Text] [Related]

  • 11. Immunological responses and protective efficacy against Brucella melitensis induced by bp26 and omp31 B. melitensis Rev.1 deletion mutants in sheep.
    Jacques I, Verger JM, Laroucau K, Grayon M, Vizcaino N, Peix A, Cortade F, Carreras F, Guilloteau LA.
    Vaccine; 2007 Jan 15; 25(5):794-805. PubMed ID: 17070627
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of Brucella melitensis B115 as rough-phenotype vaccine against B. melitensis and B. ovis infections.
    Adone R, Francia M, Ciuchini F.
    Vaccine; 2008 Sep 08; 26(38):4913-7. PubMed ID: 18675869
    [Abstract] [Full Text] [Related]

  • 13. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
    Pasquevich KA, Estein SM, García Samartino C, Zwerdling A, Coria LM, Barrionuevo P, Fossati CA, Giambartolomei GH, Cassataro J.
    Infect Immun; 2009 Jan 08; 77(1):436-45. PubMed ID: 18981242
    [Abstract] [Full Text] [Related]

  • 14. Stability of poly(epsilon-caprolactone) microparticles containing Brucella ovis antigens as a vaccine delivery system against brucellosis.
    Estevan M, Gamazo C, Martínez-Galan F, Irache JM.
    AAPS PharmSciTech; 2008 Jan 08; 9(4):1063-9. PubMed ID: 18923907
    [Abstract] [Full Text] [Related]

  • 15. A Brucella ovis antigenic complex bearing poly-epsilon-caprolactone microparticles confer protection against experimental brucellosis in mice.
    Murillo M, Grilló MJ, Reñé J, Marín CM, Barberán M, Goñi MM, Blasco JM, Irache JM, Gamazo C.
    Vaccine; 2001 Jul 20; 19(30):4099-106. PubMed ID: 11457533
    [Abstract] [Full Text] [Related]

  • 16. Aerosol infection of BALB/c mice with Brucella melitensis and Brucella abortus and protective efficacy against aerosol challenge.
    Kahl-McDonagh MM, Arenas-Gamboa AM, Ficht TA.
    Infect Immun; 2007 Oct 20; 75(10):4923-32. PubMed ID: 17664263
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of the immunogenicity and the protective efficacy in mice of a DNA vaccine encoding SP41 from Brucella melitensis.
    Al-Mariri A, Abbady AQ.
    J Infect Dev Ctries; 2013 Apr 17; 7(4):329-37. PubMed ID: 23592643
    [Abstract] [Full Text] [Related]

  • 18. Immunization of mice with a novel recombinant molecular chaperon confers protection against Brucella melitensis infection.
    Ghasemi A, Jeddi-Tehrani M, Mautner J, Salari MH, Zarnani AH.
    Vaccine; 2014 Nov 20; 32(49):6659-66. PubMed ID: 25240754
    [Abstract] [Full Text] [Related]

  • 19. Cell mediated immune response after challenge in Omp25 liposome immunized mice contributes to protection against virulent Brucella abortus 544.
    Goel D, Rajendran V, Ghosh PC, Bhatnagar R.
    Vaccine; 2013 Feb 06; 31(8):1231-7. PubMed ID: 23273966
    [Abstract] [Full Text] [Related]

  • 20. Brucella melitensis 16MΔhfq attenuation confers protection against wild-type challenge in BALB/c mice.
    Zhang J, Guo F, Chen C, Li Z, Zhang H, Wang Y, Zhang K, Du G, Li Y, Wang J, Jian T, Wang Z.
    Microbiol Immunol; 2013 Jul 06; 57(7):502-10. PubMed ID: 23647412
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.